Diurnal variability of peak expiratory flow

Journal of Asthma

Volumn 39, Issue 5, 2002, Pages 363-373

  Jindal, Surinder K ^a   Aggarwal, Ashutosh N ^a   Gupta, Dheeraj ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Circadian rhythm; Monitoring; Respiratory function tests; Respiratory hypersensitivity

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

ASTHMA; BRONCHUS HYPERREACTIVITY; CIRCADIAN RHYTHM; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HUMAN; LABORATORY DIAGNOSIS; LUNG FUNCTION TEST; MEASUREMENT; PATIENT MONITORING; PEAK EXPIRATORY FLOW; POPULATION RESEARCH; PROGNOSIS; RESPIRATORY TRACT ALLERGY; REVIEW;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGING; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; CIRCADIAN RHYTHM; HUMANS; MASS SCREENING; PEAK EXPIRATORY FLOW RATE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 0036343172     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120004029     Document Type: Review

References (64)

1. Pulmonary function laboratory in the tropics: Needs, problems and solutions
2. The pulmonary clock
3. Diurnal variation of asthma
4. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies
5. Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sample
6. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation
7. Increased peak expiratory flow variation in asthma: Severe persistent increase but not nocturnal worsening of airway inflammation
8. Peak expiratory flow variability and bronchial responsiveness to methacholine. An epidemiologic study in 117 workers
9. A comparison of three methods of measuring broncholability in asthmatics bronchitic cigarette smokers and normal subjects
10. Comparison of circadian variations using FEV1 and peak expiratory flow rates among normal and asthmatic subjects
11. Which index of peak expiratory flow is most useful in the management of stable asthma?
12. Relations between nonspecific bronchial hyperreactivity, diurnal variation of peak expiratory flow and medication requirements in patients with mild asthma
13. Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. A longitudinal study
14. Bronchial responsiveness to histamine: Relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre
15. Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma
16. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease
17. The distribution of peak expiratory flow variability in a population sample
18. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate
19. The effect of age on methacholine response
20. Intraindividual peak flow variability
21. Influence of age on diurnal variability in measurements of spirometric indices and respiratory pressures
22. Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions
23. Relation between respiratory symptoms, pulmonary function and peak flow variability in adults
24. Distribution of peak expiratory flow variability by age, gender and smoking habits in a random population sample aged 20-70 yrs.
25. Effect of ageing on peak expiratory flow variability and nocturnal exacerbations in bronchial asthma
26. Diurnal variation in lung function in subgroups from two dutch populations: Consequences for longitudinal analysis
27. Diurnal variation in peak expiratory flow in healthy young adults
28. Cosinor analysis of circadian peak expiratory flow variability in normal subjects, passive smokers, heavy smokers, patients with chronic obstructive pulmonary disease and patients with interstitial lung disease
29. Diurnal rhythms in airway obstruction
30. Seasonal variations in house dust mite influence the circadian peak expiratory flow amplitude
31. How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma?
32. Peak expiratory flow monitoring is not a reliable method for establishing the diagnosis of occupational asthma
33. Measurements of morning and evening airflow grossly underestimate the circadian variability of FEV1 and peak expiratory flow rate in asthma
34. Effect of the number of peak expiratory flow readings per day on the estimation of diurnal variation
35. Reducing the number of daily measurements results in poor estimation of diurnal variability of peak expiratory flow in healthy individuals
36. Peak expiratory flow rate variability in population surveys. Does the number of assessments matter?
37. Timing of lowest and highest peak expiratory flow in patients with asthma: Influence of anti-inflammatory treatment
38. The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease
39. Value of measuring diurnal peak flow variability in the recognition of asthma: A study in general practice
40. Validity of peak expiratory flow variability for the diagnosis of asthma
41. Assessment of diurnal variability of peak expiratory flow in stable asthmatics
42. Patients' perceptions compared with objective ratings of asthma severity
43. Determinants of different dimensions of disease severity in asthma and COPD: Pulmonary function and health-related quality of life
44. Assessment of the severity of asthma in a family practice
45. Correlates of asthma morbidity in primary care
46. Usefulness and early detection of acute exacerbation by peak expiratory flow rate in the management of asthma
47. Characteristics and prognostic value of morning dipping of peak expiratory flow rate in stable asthmatic subjects
48. A self-management plan in the treatment of adult asthma
49. Rates of change in peak expiratory flow and in diurnal variation in peak flow in patients recovering from acute severe asthma
50. Relationship between changes in diurnal variation of expiratory flows, lung volumes and respiratory symptoms after acute asthma
51. Asthma: Analysis of sudden deaths and ventilatory arrests in hospital
52. The British guidelines on asthma management. 1995 Review and position statement
53. An attempt to determine the optimal duration of hospital stay following a severe attack of asthma
54. Differences between asthma exacerbations and poor asthma control
55. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms
56. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: A comparative study
57. Diurnal variability-time to change asthma guidelines?
58. A placebo-controlled crossover comparison of salmeterol and salbutamol in patients with asthma
59. Stability of the circadian alteration in lung function in asthma
60. Variability of peak expiratory flow rate as a prognostic index in asymptomatic asthma
61. A new index of prognostic severity for chronic asthma
62. Sudden death in asthma